Aparna Group Gains US FDA Clearance for Pharma Entry

Aparna Group forays into pharma business vertical, receives US FDA clearance for Aparna Pharma manufacturing unit

Aparna Pharmaceuticals, a leader in manufacturing active pharmaceutical ingredients (APIs) and advanced drug intermediates, announced that its manufacturing facility, Aparna Organics Limited, located in Pydibhimavaram, Srikakulalam, Andhra Pradesh, India has received VAI classification from the United States Food and Drug Administration (FDA). The US FDA audited the facility during the month of September 2023.
 
This achievement underscores Aparna’s unwavering commitment to quality and compliance with global regulatory requirements. 
 

Executive’s words

Rakesh Reddy, managing director, Aparna Pharmaceuticals: “This clearance is a testament to our team’s relentless pursuit of excellence. Our facility’s compliance journey has been meticulous. We are thrilled to receive the US FDA’s stamp of approval. We are excited to contribute to global healthcare by delivering high quality pharmaceutical APIs and intermediates.”

Leader in API Manufacturing

With the successful completion of the FDA audit, Aparna Pharmaceuticals has emerged as a leading manufacturer of APIs and advanced drug intermediates and attained global recognition by providing high quality products manufactured as per cGMP guidelines. Driven by innovative R&D and optimum utilization of resources, the company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!